Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride may cause breast enlargement, low testosterone a risk factor.

CT scans can find serious prostate cancer even when PSA levels are low.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.